Literature DB >> 17391107

The TB pandemic: an old problem seeking new solutions.

D B Meya1, K P W J McAdam.   

Abstract

Tuberculosis (TB) continues to kill more than 2 million people globally each year. Annual TB case notification rates have risen up to fourfold since the mid-1980s, with the highest rate of 1000/100,000 around Cape Town, South Africa. There is an urgent need for novel diagnostic methods and preventive vaccines to control this epidemic. The rising incidence of TB has been attributed to HIV co-infection especially in developing countries. The threat of drug resistance arising from ineffective TB treatment programmes is looming and could potentially lead to loss of any gains made in controlling the disease globally.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391107     DOI: 10.1111/j.1365-2796.2007.01795.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  27 in total

1.  Predicting the in vivo mechanism of action for drug leads using NMR metabolomics.

Authors:  Steven Halouska; Robert J Fenton; Raúl G Barletta; Robert Powers
Journal:  ACS Chem Biol       Date:  2011-12-01       Impact factor: 5.100

2.  Potent inhibitors of a shikimate pathway enzyme from Mycobacterium tuberculosis: combining mechanism- and modeling-based design.

Authors:  Sebastian Reichau; Wanting Jiao; Scott R Walker; Richard D Hutton; Edward N Baker; Emily J Parker
Journal:  J Biol Chem       Date:  2011-03-15       Impact factor: 5.157

3.  CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.

Authors:  Shuyu Yao; Dan Huang; Crystal Y Chen; Lisa Halliday; Richard C Wang; Zheng W Chen
Journal:  J Immunol       Date:  2014-01-31       Impact factor: 5.422

4.  A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1.

Authors:  Xiaoman Li; Wei Xu; Sidong Xiong
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

Review 5.  Epidemiology and treatment of multidrug resistant tuberculosis.

Authors:  Carole D Mitnick; Sasha C Appleton; Sonya S Shin
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

6.  Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis.

Authors:  Nicholas P West; Teresa M Wozniak; Jesus Valenzuela; Carl G Feng; Alan Sher; Jose M C Ribeiro; Warwick J Britton
Journal:  Vaccine       Date:  2008-05-23       Impact factor: 3.641

7.  HIV/TB co-infection in mainland China: a meta-analysis.

Authors:  Lei Gao; Feng Zhou; Xiangwei Li; Qi Jin
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

8.  Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis.

Authors:  Guglielmo Lucchese; Angela Stufano; Darja Kanduc
Journal:  J Biomed Biotechnol       Date:  2010-06-03

9.  Effect of pulmonary tuberculosis on mortality in patients receiving HAART.

Authors:  Daniel Westreich; Patrick MacPhail; Annelies Van Rie; Babatyi Malope-Kgokong; Prudence Ive; Dennis Rubel; Ronan Boulmé; Joseph Eron; Ian Sanne
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177

Review 10.  Managing tuberculosis and HIV in sub-Sahara Africa.

Authors:  Umesh G Lalloo; Sandy Pillay
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.